NU
NUS.US Nu Skin Enterprises Inc
- Market cap
- USD 196M
- P/E
- -
- P/B
- 0.36x
- ROE
- -60.6%
- Dividend yield
- 6.03%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is NUS.US undervalued?
Graham numberThe Graham number of Nu Skin Enterprises Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nu Skin Enterprises Inc fundamental analysis
No fundamental analysis for Nu Skin Enterprises Inc yet.
Nu Skin Enterprises Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provide…
Full company profileNu Skin Enterprises Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nu Skin Enterprises Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 2.21B | 2.28B | 2.68B | 2.42B | 2.58B | 2.70B | 2.23B | 1.97B | 1.73B | 1.49B | 1.27B |
| Gross Profit | 1.71B | 1.78B | 2.04B | 1.84B | 1.92B | 2.02B | 1.59B | 1.36B | 1.18B | 1.03B | 847M |
| Operating Income | 231M | 274M | 241M | 267M | 258M | 234M | 111M | 48.3M | -152M | 90.9M | -64.5M |
| EBITDA | 304M | 346M | 303M | 344M | 332M | 320M | 175M | 205M | -78.8M | 262M | -5.08M |
| Net Income | 143M | 129M | 122M | 174M | 191M | 147M | 105M | 8.60M | -147M | 160M | -332M |
| EPS | 2.55 | 2.36 | 2.16 | 3.10 | 3.63 | 2.86 | 2.07 | 0.17 | -2.95 | 3.18 | -6.81 |
| Balance Sheet | |||||||||||
| Total Assets | 1.47B | 1.59B | 1.69B | 1.77B | 1.96B | 1.91B | 1.82B | 1.81B | 1.47B | 1.41B | 1.09B |
| Total Liabilities | 810M | 885M | 913M | 894M | 1.06B | 994M | 924M | 984M | 817M | 600M | 541M |
| Shareholders' Equity | 664M | 705M | 782M | 875M | 894M | 913M | 897M | 822M | 651M | 805M | 547M |
| Cash & Short-term Investments | 368M | 438M | 398M | 344M | 424M | 355M | 279M | 268M | 198M | 240M | 167M |
| Total Debt | 417M | 389M | 430M | 507M | 500M | 504M | 521M | 607M | 478M | 364M | 252M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 275M | 303M | 203M | 178M | 379M | 142M | 108M | 119M | 112M | 80.3M | -1.89M |
| Capital Expenditure | 50.2M | 60.2M | 70.4M | 66.1M | 63.8M | 68.6M | 59.1M | 58.5M | 41.6M | 34.3M | 40.9M |
| Free Cash Flow | 225M | 242M | 132M | 112M | 315M | 73.0M | 49.0M | 60.1M | 70.2M | 46.0M | -42.8M |
| Ratios | |||||||||||
| ROE | 21.5% | 18.4% | 15.6% | 19.8% | 21.4% | 16.1% | 11.7% | 1.0% | -22.5% | 19.9% | -60.6% |
| ROA | 9.7% | 8.1% | 7.2% | 9.8% | 9.8% | 7.7% | 5.8% | 0.5% | -10.0% | 11.4% | -30.5% |
| Net Profit Margin | 6.5% | 5.7% | 4.5% | 7.2% | 7.4% | 5.5% | 4.7% | 0.4% | -8.5% | 10.8% | -26.1% |
| Debt to Equity | 0.63x | 0.55x | 0.55x | 0.58x | 0.56x | 0.55x | 0.58x | 0.74x | 0.73x | 0.45x | 0.46x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Nu Skin Enterprises Inc dividends
- Dividend yield
- 6.03%
- Forward dividend
- 0.24 USD
- Payout ratio
- 7.4%
- Ex-dividend date
- Nov 27, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 11.8M | 0.24 | 7.4% |
| 2024 | USD 11.9M | 0.24 | - |
| 2023 | USD 77.6M | 1.56 | 903.1% |
| 2022 | USD 77.0M | 1.52 | 73.5% |
| 2021 | USD 76.3M | 1.48 | 51.8% |
| 2020 | USD 78.4M | 1.49 | 41.0% |
| 2019 | USD 82.2M | 1.47 | 47.4% |
| 2018 | USD 80.6M | 1.43 | 66.1% |
| 2017 | USD 76.1M | 1.39 | 58.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Nu Skin Enterprises Inc
- Insiders 3.44%
- Institutions 75.56%
- Public & others 21.00%
- Shares outstanding 48.7M
- Free float 47.3M
Top funds holding NUS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Avantis US Small Cap Value ETF | 2.54M | 5.21% | +0.43% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 1.47M | 3.01% | 0.00% | Sep 2026 |
| iShares Russell 2000 ETF | 1.30M | 2.68% | 0.00% | Oct 2026 |
| Vanguard Strategic Small-Cap Equity Inv | 596K | 1.22% | 0.00% | Sep 2026 |
| Vanguard Consumer Staples ETF | 554K | 1.14% | -1.58% | Sep 2026 |
| Fidelity Small Cap Index | 545K | 1.12% | 0.00% | Aug 2026 |
| DFA U.S. Small Cap Value I | 539K | 1.11% | +51.83% | Sep 2026 |
| Schwab Fundamental U.S. Small CompanyETF | 525K | 1.08% | 0.00% | Oct 2026 |
| iShares Russell 2000 Value ETF | 497K | 1.02% | 0.00% | Oct 2026 |
| Vanguard Russell 2000 ETF | 279K | 0.57% | -0.30% | Sep 2026 |
| Schwab US Small-Cap ETF™ | 269K | 0.55% | +0.24% | Oct 2026 |
| PIMCO RAE US S Instl | 258K | 0.53% | +14.06% | Jun 2026 |
| DFA U.S. Targeted Value I | 250K | 0.51% | 0.00% | Sep 2026 |
| Fidelity Extended Market Index | 231K | 0.47% | +56.02% | Sep 2026 |
| EA Bridgeway Omni Small-Cap Value ETF | 229K | 0.47% | 0.00% | Oct 2026 |
| WisdomTree US SmallCap Dividend ETF | 229K | 0.47% | 0.00% | Oct 2026 |
| Dimensional US Small Cap Value ETF | 223K | 0.46% | 0.00% | Sep 2026 |
| AST PGIM Aggressive Multi-Asset Port | 154K | 0.32% | 0.00% | Sep 2026 |
| First Trust Active Factor Mid Cap ETF | 150K | 0.31% | 0.00% | Oct 2026 |
| Vanguard US Value Factor ETF | 149K | 0.31% | +20.67% | Sep 2026 |
Top institutions holding NUS.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 4.32M | 8.87% | +0.57% | Jun 2026 |
| American Century Companies Inc | 2.69M | 5.53% | +16.97% | Sep 2026 |
| Vanguard Capital Management, LLC | 2.05M | 4.21% | -0.66% | Jun 2026 |
| Acadian Asset Management LLC | 1.95M | 4.00% | -0.25% | Sep 2026 |
| Prescott Group Capital Management LLC | 1.79M | 3.69% | 0.00% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 1.74M | 3.57% | +1.60% | Jun 2026 |
| Renaissance Technologies Corp | 1.54M | 3.15% | -4.50% | Sep 2026 |
| Charles Schwab Investment Management Inc | 1.45M | 2.98% | -32.21% | Jun 2026 |
| CastleKnight Management LP | 1.39M | 2.85% | +43.94% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 1.34M | 2.75% | -25.37% | Sep 2026 |
| Geode Capital Management, LLC | 1.27M | 2.61% | +6.82% | Jun 2026 |
| Two Sigma Investments LLC | 1.17M | 2.40% | +15.46% | Jun 2026 |
| State Street Corp | 1.01M | 2.07% | -2.33% | Jun 2026 |
| Prudential Financial Inc | 926K | 1.90% | +145.83% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 906K | 1.86% | +9.05% | Jun 2026 |
| AQR Capital Management LLC | 789K | 1.62% | -36.17% | Jun 2026 |
| Citadel Advisors Llc | 655K | 1.34% | +187.87% | Jun 2026 |
| SG Americas Securities, LLC | 625K | 1.28% | 0.00% | Jun 2026 |
| The Goldman Sachs Group Inc | 619K | 1.27% | -17.37% | Jun 2026 |
| Bank of New York Mellon Corp | 542K | 1.11% | +0.25% | Jun 2026 |
Nu Skin Enterprises Inc company profile
- Company name
- Nu Skin Enterprises Inc
- Ticker
- NUS.US
- Exchange
- USA Stocks
- Listed since
- Nov 21, 1996
- Sector
- Consumer Defensive
- Industry
- Personal Care Products
- Employees
- 2,800
- Fiscal year end
- December
- Address
- 75 West Center Street, Provo, UT, United States, 84601
- Phone
- 801 345 1000
- Website
- nuskin.com
About Nu Skin Enterprises Inc
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands. The company also provides wellness products, such as ageLOC TRME, LifePak, and Beauty Focus. In addition, it is the research and product development of skin care products, nutritional supplements, and devices. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center and independent marketers. It serves Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, comprising Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, consists of Macau; and Europe & Africa, which includes markets in Europe as well as South Africa. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Nu Skin Enterprises Inc management
10- Mr. Steven J. Lund J.D.Co-Founder & Executive Chairman of the Board · born 1953
- Mr. Ryan S. NapierskiPresident, CEO & Director · born 1974
- Mr. Chayce David ClarkExecutive VP, COO & Chief Legal Officer · born 1983
- Mr. Justin S. KeiselExecutive VP & President of Global Sales (Leave of Absence) · born 1974
- Mr. Blake M. RoneyFounder · born 1959
- Ms. Sandra N. TillotsonFounder · born 1957
- Ms. Chelsea LantzChief Financial Officer · born 1984
- Mr. Joe SueperSenior VP & CTO
- Dr. Joseph Y. Chang Ph.D.Executive VP, Chief Scientific Officer & Chair of Scientific Advisory Board · born 1953
- Mr. B.G. HuntVP of Treasurer, Investor Relations & Admin Services